The stock of Tevogen Bio Holdings Inc (TVGN) has gone down by -3.18% for the week, with a 11.88% rise in the past month and a 13.56% rise in the past quarter. The volatility ratio for the week is 6.55%, and the volatility levels for the past 30 days are 11.21% for TVGN. The simple moving average for the past 20 days is -0.27% for TVGN’s stock, with a 50.09% simple moving average for the past 200 days.
Is It Worth Investing in Tevogen Bio Holdings Inc (NASDAQ: TVGN) Right Now?
Moreover, the 36-month beta value for TVGN is -1.12. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for TVGN is 24.92M and currently, short sellers hold a 11.14% of that float. On February 21, 2025, TVGN’s average trading volume was 2.59M shares.
TVGN) stock’s latest price update
The stock of Tevogen Bio Holdings Inc (NASDAQ: TVGN) has decreased by -2.55 when compared to last closing price of 1.55. Despite this, the company has experienced a -3.18% fall in its stock price over the last five trading sessions. globenewswire.com reported 2025-02-14 that WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) — Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company, reaffirms his commitment to preserving equity for shareholders. Amid ongoing discussions about financing approaches in the biotech sector, Dr. Saadi emphasizes his distinct strategy, which prioritizes efficiency, asset ownership, and a path to revenue.
TVGN Trading at 16.91% from the 50-Day Moving Average
After a stumble in the market that brought TVGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.21% of loss for the given period.
Volatility was left at 11.21%, however, over the last 30 days, the volatility rate increased by 6.55%, as shares surge +10.15% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +34.52% upper at present.
During the last 5 trading sessions, TVGN fell by -2.56%, which changed the moving average for the period of 200-days by +56.71% in comparison to the 20-day moving average, which settled at $1.5150. In addition, Tevogen Bio Holdings Inc saw 46.64% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TVGN starting from Flomenberg Neal, who sale 1,078,600 shares at the price of $1.62 back on Oct 17 ’24. After this action, Flomenberg Neal now owns 4,254,302 shares of Tevogen Bio Holdings Inc, valued at $1,747,332 using the latest closing price.
Desai Kirti, the Chief Financial Officer of Tevogen Bio Holdings Inc, purchase 3,000 shares at $0.82 during a trade that took place back on Jun 12 ’24, which means that Desai Kirti is holding 9,699,186 shares at $2,460 based on the most recent closing price.
Stock Fundamentals for TVGN
The total capital return value is set at 7.32. Equity return is now at value -124.74, with -14.86 for asset returns.
Based on Tevogen Bio Holdings Inc (TVGN), the company’s capital structure generated -0.92 points at debt to capital in total, while cash flow to debt ratio is standing at -3.25. The debt to equity ratio resting at -0.48. The interest coverage ratio of the stock is -105.71.
Currently, EBITDA for the company is 0.19 million with net debt to EBITDA at -0.19. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.34.
Conclusion
To wrap up, the performance of Tevogen Bio Holdings Inc (TVGN) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
